Eva Live registers 5 million share put with Hudson Global Ventures

Eva Live Inc. has filed a prospectus supplement registering the potential issuance of up to 5,000,000 shares of its common stock to Hudson Global Ventures, LLC. The registration, filed with the U.S. Securities and Exchange Commission on October 19, 2026, covers the securities under an Equity Purchase Agreement signed by the two parties on September 17, 2026. This filing follows a prior disclosure by the company in a Form 8-K dated September 23, 2026.

Under the terms of the Purchase Agreement, Eva Live holds the right, but not the obligation, to direct Hudson Global Ventures to purchase the shares from time to time. The aggregate purchase price for these shares, referred to as Put Shares, is capped at $10,000,000. The common stock carries a par value of $0.0001 per share and trades on The Nasdaq Stock Market LLC under the symbol GOAI.

In connection with this agreement, the company issued a Common Stock Purchase Warrant to the investor on September 17, 2026. This warrant grants the investor the right to purchase an additional 275,000 shares of common stock. The warrant is exercisable at any time for five years from the issuance date at a fixed exercise price of $0.01 per share.

The issuance of both the Put Shares and the Warrant Shares was registered pursuant to Eva Live's shelf registration statement on Form S-3. That base registration statement, assigned File No. 333-294416, was originally filed with the Commission on March 18, 2026, and declared effective on March 24, 2026. The current prospectus supplement forms part of this broader registration framework.

The company is headquartered at 8488 Rozita Lee Ave Building 3 in Las Vegas, Nevada. David Boulette, President and CEO of Eva Live Inc., signed the report on October 19, 2026. An opinion letter from Sichenzia Ross Ference Carmel LLP was included as an exhibit to the filing.